334 related articles for article (PubMed ID: 37145596)
21. Preventive Intake of a Multiple Micronutrient Supplement during Mild, Acute SARS-CoV-2 Infection to Reduce the Post-Acute COVID-19 Condition: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Tomasa-Irriguible TM; Monfà R; Miranda-Jiménez C; Morros R; Robert N; Bordejé-Laguna L; Vidal S; Torán-Monserrat P; Barriocanal AM
Nutrients; 2024 May; 16(11):. PubMed ID: 38892564
[TBL] [Abstract][Full Text] [Related]
22. Extended coagulation profile of children with Long Covid: a prospective study.
Di Gennaro L; Valentini P; Sorrentino S; Ferretti MA; De Candia E; Basso M; Lancellotti S; De Cristofaro R; De Rose C; Mariani F; Morello R; Lazzareschi I; Sigfrid L; Munblit D; Buonsenso D
Sci Rep; 2022 Nov; 12(1):18392. PubMed ID: 36319840
[TBL] [Abstract][Full Text] [Related]
23. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.
Matta J; Wiernik E; Robineau O; Carrat F; Touvier M; Severi G; de Lamballerie X; Blanché H; Deleuze JF; Gouraud C; Hoertel N; Ranque B; Goldberg M; Zins M; Lemogne C;
JAMA Intern Med; 2022 Jan; 182(1):19-25. PubMed ID: 34747982
[TBL] [Abstract][Full Text] [Related]
24. Functional Limitations and Exercise Intolerance in Patients With Post-COVID Condition: A Randomized Crossover Clinical Trial.
Tryfonos A; Pourhamidi K; Jörnåker G; Engvall M; Eriksson L; Elhallos S; Asplund N; Mandic M; Sundblad P; Sepic A; Rullman E; Hyllienmark L; Rundqvist H; Lundberg TR; Gustafsson T
JAMA Netw Open; 2024 Apr; 7(4):e244386. PubMed ID: 38573638
[TBL] [Abstract][Full Text] [Related]
25. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
26. Olfactory dysfunction as an early predictor for post-COVID condition at 1-year follow-up.
Granvik C; Andersson S; Andersson L; Brorsson C; Forsell M; Ahlm C; Normark J; Edin A
Brain Behav; 2024 Jun; 14(6):e3574. PubMed ID: 38841730
[TBL] [Abstract][Full Text] [Related]
27. Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population.
Thi Khanh HN; Cornelissen L; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P
BMC Infect Dis; 2023 Nov; 23(1):774. PubMed ID: 37940843
[TBL] [Abstract][Full Text] [Related]
28. Association of Initial SARS-CoV-2 Test Positivity With Patient-Reported Well-being 3 Months After a Symptomatic Illness.
Wisk LE; Gottlieb MA; Spatz ES; Yu H; Wang RC; Slovis BH; Saydah S; Plumb ID; O'Laughlin KN; Montoy JCC; McDonald SA; Lin Z; Lin JS; Koo K; Idris AH; Huebinger RM; Hill MJ; Gentile NL; Chang AM; Anderson J; Hota B; Venkatesh AK; Weinstein RA; Elmore JG; Nichol G;
JAMA Netw Open; 2022 Dec; 5(12):e2244486. PubMed ID: 36454572
[TBL] [Abstract][Full Text] [Related]
29. Cross-sectional study evaluating the impact of SARS-CoV-2 variants on Long COVID outcomes in UK hospital survivors.
Saigal A; Nagoda Niklewicz C; Naidu SB; Bintalib HM; Shah AJ; Seligmann G; Hunter AS; Wey E; Abubakar I; Mahungu T; Miller D; Barnett J; Jain NG; Brill S; Goldring J; Jarvis H; Smith C; Ogbonnaya C; Hurst JR; Lipman MCI; Mandal S
BMJ Open Respir Res; 2023 Aug; 10(1):. PubMed ID: 37536948
[TBL] [Abstract][Full Text] [Related]
30. Digital Patient Reported Outcome Measures Platform for Post-COVID-19 Condition and Other Long-Term Conditions: User-Centered Development and Technical Description.
Sivan M; Rocha Lawrence R; O'Brien P
JMIR Hum Factors; 2023 Oct; 10():e48632. PubMed ID: 37665334
[TBL] [Abstract][Full Text] [Related]
31. Rates and Factors Associated With Documentation of Diagnostic Codes for Long COVID in the National Veterans Affairs Health Care System.
Ioannou GN; Baraff A; Fox A; Shahoumian T; Hickok A; O'Hare AM; Bohnert ASB; Boyko EJ; Maciejewski ML; Bowling CB; Viglianti E; Iwashyna TJ; Hynes DM
JAMA Netw Open; 2022 Jul; 5(7):e2224359. PubMed ID: 35904783
[TBL] [Abstract][Full Text] [Related]
32. Female gender is associated with long COVID syndrome: a prospective cohort study.
Bai F; Tomasoni D; Falcinella C; Barbanotti D; Castoldi R; Mulè G; Augello M; Mondatore D; Allegrini M; Cona A; Tesoro D; Tagliaferri G; Viganò O; Suardi E; Tincati C; Beringheli T; Varisco B; Battistini CL; Piscopo K; Vegni E; Tavelli A; Terzoni S; Marchetti G; Monforte AD
Clin Microbiol Infect; 2022 Apr; 28(4):611.e9-611.e16. PubMed ID: 34763058
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
34. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
PHOSP-COVID Collaborative Group
Lancet Respir Med; 2022 Aug; 10(8):761-775. PubMed ID: 35472304
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of SARS-CoV-2-Positive Youths Tested in Emergency Departments: The Global PERN-COVID-19 Study.
Funk AL; Florin TA; Kuppermann N; Tancredi DJ; Xie J; Kim K; Neuman MI; Ambroggio L; Plint AC; Mintegi S; Klassen TP; Salvadori MI; Malley R; Payne DC; Simon NJ; Yock-Corrales A; Nebhrajani JR; Chaudhari PP; Breslin KA; Finkelstein Y; Campos C; Bergmann KR; Bhatt M; Ahmad FA; Gardiner MA; Avva UR; Shah NP; Sartori LF; Sabhaney VJ; Caperell K; Navanandan N; Borland ML; Morris CR; Gangoiti I; Pavlicich V; Kannikeswaran N; Lunoe MM; Rino PB; Kam AJ; Cherry JC; Rogers AJ; Chong SL; Palumbo L; Angelats CM; Morrison AK; Kwok MY; Becker SM; Dixon AC; Poonai N; Eckerle M; Wassem M; Dalziel SR; Freedman SB;
JAMA Netw Open; 2022 Jan; 5(1):e2142322. PubMed ID: 35015063
[TBL] [Abstract][Full Text] [Related]
37. Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.
Stankiewicz Karita HC; Dong TQ; Johnston C; Neuzil KM; Paasche-Orlow MK; Kissinger PJ; Bershteyn A; Thorpe LE; Deming M; Kottkamp A; Laufer M; Landovitz RJ; Luk A; Hoffman R; Roychoudhury P; Magaret CA; Greninger AL; Huang ML; Jerome KR; Wener M; Celum C; Chu HY; Baeten JM; Wald A; Barnabas RV; Brown ER
JAMA Netw Open; 2022 Jan; 5(1):e2142796. PubMed ID: 35006245
[TBL] [Abstract][Full Text] [Related]
38. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
[TBL] [Abstract][Full Text] [Related]
39. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
40. Association of Post-COVID-19 Condition Symptoms and Employment Status.
Perlis RH; Lunz Trujillo K; Safarpour A; Santillana M; Ognyanova K; Druckman J; Lazer D
JAMA Netw Open; 2023 Feb; 6(2):e2256152. PubMed ID: 36790806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
